Search Results - "Ribecco, Angela S."
-
1
The national COVID-19 vaccination campaign targeting the extremely vulnerable: the Florence Medical Oncology Unit experience in patients with cancer
Published in European journal of cancer (1990) (01-07-2022)“…International and national oncology societies had released recommendations in favor of COVID-19 vaccination in cancer patients. In the context of the national…”
Get full text
Journal Article -
2
Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave
Published in European journal of cancer (1990) (01-05-2021)“…The novel coronavirus disease 2019 (COVID-19) pandemic has been an overwhelming challenge for worldwide health systems. Since the beginning of year 2020,…”
Get full text
Journal Article -
3
Consensus document of the Italian Association of Medical Oncology and the Italian Society of Palliative Care on early palliative care
Published in Tumori (01-04-2019)“…A consensus document on early palliative care was produced by a committed Working Group of the Italian Society of Medical Oncology and the Italian Society of…”
Get full text
Journal Article -
4
Molecularly targeted therapy: toxicity and quality of life considerations in advanced colorectal cancer
Published in Expert review of anticancer therapy (01-10-2013)“…Colorectal cancer (CRC) is the third most common malignancy and cause of death from cancer among adults worldwide. In recent years, the use of…”
Get full text
Journal Article -
5
Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO)
Published in Supportive care in cancer (01-03-2019)“…Background Fatigue is one of the most distressing symptoms of cancer patients. Its characteristics and impact on quality of life have not been fully explored…”
Get full text
Journal Article -
6
Abstract P3-05-45: Circulating tumor cells, immunohistochemical subtypes, and genes mutation as prognostic markers in HER2 negative metastatic breast cancer patients candidates to chemotherapy
Published in Cancer research (Chicago, Ill.) (01-03-2023)“…Abstract Background: In the era of targeted therapies, chemotherapy (CT) is still a valuable treatment option for patients (pts) with HER2 negative metastatic…”
Get full text
Journal Article